Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma.
Ng HHM, Lee RY, Goh S, Tay ISY, Lim X, Lee B, Chew V, Li H, Tan B, Lim S, Lim JCT, Au B, Loh JJH, Saraf S, Connolly JE, Loh T, Leow WQ, Lee JJX, Toh HC, Malavasi F, Lee SY, Chow P, Newell EW, Choo SP, Tai D, Yeong J, Lim TKH.
Ng HHM, et al. Among authors: lee ry, lee sy, lee jjx, lee b.
J Immunother Cancer. 2020 Aug;8(2):e000987. doi: 10.1136/jitc-2020-000987.
J Immunother Cancer. 2020.
PMID: 32847986
Free PMC article.